Story perspectives

Law Firms Challenge Bayer's $7.25B Roundup Settlement Terms

2/26/2026

Summary

Story summary

Fourteen law firms representing 20,000 plaintiffs filed motions in Missouri to intervene in Bayer's proposed Roundup settlement worth $7.25 billion.
They argue the deal disproportionately favors occupational users over residential Roundup users.
Bayer, facing over 200,000 lawsuits since acquiring Monsanto, says the settlement is fair and avoids bankruptcy.
Bayer is appealing to the U.S. Supreme Court, citing federal preemption and support from U.S. President Donald Trump and the Environmental Protection Agency.

History

Historical Context

Bayer's $7.25 billion settlement in 2020 aimed to resolve over 200,000 lawsuits alleging that its glyphosate-based herbicide, Roundup, causes cancer. This legal struggle follows the 2015 IARC classification of glyphosate as "probably carcinogenic" and mirrors the 1998 Tobacco Master Settlement Agreement, highlighting ongoing conflicts between corporate practices, public health, and regulatory oversight in the U.S.

1 of 2

Story summary

Fourteen law firms representing 20,000 plaintiffs filed motions in Missouri to intervene in Bayer's proposed Roundup settlement worth $7.25 billion.
They argue the deal disproportionately favors occupational users over residential Roundup users.
Bayer, facing over 200,000 lawsuits since acquiring Monsanto, says the settlement is fair and avoids bankruptcy.
Bayer is appealing to the U.S. Supreme Court, citing federal preemption and support from U.S. President Donald Trump and the Environmental Protection Agency.

1 / 2